Understanding kidney disease relies on defining the complexity of cell types and states, their
associated molecular profiles and interactions within tissue neighbourhoods 1 . Here we …

Chronic kidney disease (CKD) affects 8 to 16% people worldwide, with an increasing incidence
and prevalence of end-stage kidney disease (ESKD). The effective management of CKD …

Thyroid hormones influence renal development, kidney structure, renal hemodynamics, GFR,
the function of many transport systems along the nephron, and sodium and water …

Glomerulonephritis (GN) is an important cause of morbidity and mortality in patients of all
ages throughout the world. Because these disorders are relatively rare, it is difficult to perform …

Membranous Nephropathy (MN) is a rare autoimmune cause of kidney failure. Here we
report a genome-wide association study (GWAS) for primary MN in 3,782 cases and 9,038 …

Chronic kidney disease (CKD) and acute kidney injury (AKI) are common, heterogeneous,
and morbid diseases. Mechanistic characterization of CKD and AKI in patients may facilitate a …

Chronic kidney diseases (CKDs) are currently classified according to their clinical features,
associated comorbidities and pattern of injury on biopsy. Even within a given classification, …

Metformin, the most widely prescribed medication for obesity-associated type 2 diabetes (T2D),
lowers plasma glucose levels, food intake, and body weight in rodents and humans, but …

It has been suggested that soluble urokinase receptor (suPAR) is a causative circulating
factor for and a biomarker of focal and segmental glomerulosclerosis (FSGS). Here we …

APOL1 variants have been associated with renal phenotypes in blacks. To refine clinical
outcomes and discover mechanisms of APOL1-associated kidney injury, we analyzed clinical …